On November 20, 2023 Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, reported that management, will participating in two upcoming investor conferences (Press release, Ultragenyx Pharmaceutical, NOV 20, 2023, View Source [SID1234637862]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

6th Annual Evercore ISI HealthCONx (Miami, FL)

Tuesday, November 28, 2023, management will host 1×1 meetings.

Piper Sandler 35th Annual Healthcare Conference (New York City, NY)

Wednesday, November 29, 2023, at 10:00am, Emil Kakkis, M.D., Ph.D., CEO and President, will participate in a fireside chat and host 1×1 meetings.
The live and archived webcast of the fireside chat will be accessible from the company’s website at View Source